|
Title
|
|
|
|
Antibiotic use in eastern Europe : a cross-national database study in coordination with the WHO Regional Office for Europe
|
|
|
Author
|
|
|
|
|
|
|
Institution/Organisation
|
|
|
|
WHO Europe-ESAC Project Group
|
|
|
Abstract
|
|
|
|
| Background There are no reliable data on antibiotic use in non-European Union (EU) southern and eastern European countries and newly independent states. We aimed to collect valid, representative, comparable data on systemic antimicrobial use in these non-EU countries of the WHO European region. Methods Validated 2011 total national wholesale antibiotic-use data of six southern and eastern European countries and regions and seven newly independent states were analysed in accordance with the WHO anatomical therapeutic chemical (ATC)/defined daily doses (DDD) method and expressed in DDD/1000 inhabitants per day (DID). Findings Total (outpatients and hospital care) antibiotic use ranged from 15-3 DID for Armenia to 42-3 DID for Turkey. Co-amoxidav was mainly used in Georgia (42.9% of total antibiotic use) and Turkey (30.7%). Newly independent states used substantial quantities of ampicillin and amoxicillin (up to 55.9% of total antibiotic use in Azerbaijan). Montenegro and Serbia were the highest consumers of macrolides (15-8% and 19.5% of total antibiotic use, respectively), mainly azithromydn. Parenteral antibiotic treatment is common practice: 46.4% of total antibiotic use in Azerbaijan (mainly ampicillin; 5.3 DID) and 31.1% of total antibiotic use in Tajikistan (mainly ceftriaxone; 4.7 DID). Interpretation This study provides publicly available total antibiotic-use data for 13 non-EU countries and areas of the WHO European region. These data will raise awareness of inappropriate antibiotic use and stimulate policy makers to develop action plans. The established surveillance system provides a method to develop quality indicators of antibiotic use and to assess the effect of policy and regulatory actions. Copyright (c) 2014. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
The lancet infectious diseases. - London
|
|
|
Publication
|
|
|
|
London
:
2014
|
|
|
ISSN
|
|
|
|
1473-3099
|
|
|
DOI
|
|
|
|
10.1016/S1473-3099(14)70071-4
|
|
|
Volume/pages
|
|
|
|
14
:5
(2014)
, p. 381-387
|
|
|
ISI
|
|
|
|
000335093200022
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|